In this application, we show how the HPLC method for simvastatin has been redeveloped on UPLC and is compatible for MS. The analytical goals were to meet the requirements stated in the USP 30 - NF 25 monograph for simvastatin drug substance for chromatographic purity and possibly be used for the assay. Empower 2 custom reporting, custom fields, and spectral analysis were used in streamlining the decision making process during method development. The utilization of the ACQUITY UPLC system and Empower 2 software provided a timely solution to the method development challenges associated with impurity profiling.
Title | Format | File Size |
---|---|---|
720002185en | 1784.82kB |